Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
Australian Indigenous HealthBulletin
 
  • Home
    • » Key resources and services
      • » Programs and projects
        • » ETHOS cohort (Enhancement treatment for hepatitis C in opioid substitution settings)

ETHOS cohort (Enhancement treatment for hepatitis C in opioid substitution settings)

 

Overview

The purpose of the study is to examine hepatitis C virus (HCV) treatment uptake, response to therapy and reinfection following successful treatment among patients with chronic HCV infection and a history of injection drug use.

The specific objectives of this study are to examine:

Abstract adapted from The Kirby Institute for Infection and Immunity in Society

Contacts

The Kirby Institute for Infection and Immunity in Society
101 West Streets
Darlinghurst NSW 2010
Ph: (02) 9385 0900
Fax: (02) 9385 0920
Email: recpt@nchecr.unsw.edu.au

Links

 
Last updated: 18 June 2014
 
Return to top